The main purpose of this legislation is to improve oversight and accountability within key health agencies in the United States. Specifically, it aims to establish Inspector Generals for the National Institutes of Health (NIH), the Centers for Disease Control and Prevention (CDC), and the Food and Drug Administration (FDA). These positions are intended to enhance public health, safety, ethics, and the integrity of clinical trials.